Skip to main content
Premium Trial:

Request an Annual Quote

Baylor, U Minn, Mayo Adopt Open Biosystems' RNAi Program

NEW YORK (GenomeWeb News) — Open Biosystems yesterday said that three US research centers have adopted its RNAi Program, which gives access to the company’s shRNA libraries, technical support, and access to extensions of existing libraries.
 
Baylor College of Medicine, the University of Minnesota, and the Mayo Clinic will use the Open Biosystems programs in several types of genome studies, the company said.
 
Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviral and retroviral libraries targeting the entire human and mouse genomes, the RNAi Consortium human and mouse lentiviral shRNA libraries, lentiviral inducible shRNAmir library targeting the human genome, and RNAi collections targeting Drosophila, C. elegans, and zebrafish.
 
Financial terms of the agreements were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more